Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up.
Lists
Only you see this
Abstract
In our study, lower doses were administered compared with previous short-time trials. The present data show that interferon is an effective alternative to cytostatic agents in long-term treatment of patients with essential thrombocythemia, even when used at lower dosages.
BibTeX
@inproceedings{tassi1996alpha,
author = {E. ̃Tassi and Fausto Rossini and Isabella Miccolis and Andrea Ferrario and Daniele Perego and Ivana Casaroli and Samer Bolis and Daniele Fagnani and Marco Brambilla and G Corneo},
title = {{Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up.}},
booktitle = {PubMed},
year = {1996},
doi = {10.1177/030089169508100406},
}Loading related content...